McKesson Corporation (0JZU.L)
USD 693.0
(0.42%)
USD 693.0
(0.42%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 8.67 Billion USD | 16.98% |
| 2022 | 7.41 Billion USD | -25.29% |
| 2021 | 9.92 Billion USD | 22.97% |
| 2020 | 8.07 Billion USD | -3.77% |
| 2019 | 8.38 Billion USD | 9.16% |
| 2018 | 7.68 Billion USD | 2.85% |
| 2017 | 7.47 Billion USD | 1.91% |
| 2016 | 7.33 Billion USD | 3.37% |
| 2015 | 7.09 Billion USD | -15.58% |
| 2014 | 8.4 Billion USD | 40.39% |
| 2013 | 5.98 Billion USD | 26.7% |
| 2012 | 4.72 Billion USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.12 Billion USD | 1.53% |
| 2023 Q1 | 1.77 Billion USD | -4.88% |
| 2023 Q2 | 2 Billion USD | 12.68% |
| 2023 FY | 8.27 Billion USD | 11.58% |
| 2023 Q3 | 2.4 Billion USD | 20.45% |
| 2023 Q4 | 2.09 Billion USD | -13.2% |
| 2022 Q2 | 1.86 Billion USD | -0.53% |
| 2022 Q1 | 1.87 Billion USD | -23.06% |
| 2022 Q4 | 1.86 Billion USD | 2.75% |
| 2022 FY | 7.41 Billion USD | -25.29% |
| 2022 Q3 | 1.81 Billion USD | -2.47% |
| 2021 FY | 9.92 Billion USD | 22.97% |
| 2021 Q1 | 2.09 Billion USD | 2.05% |
| 2021 Q2 | 2.54 Billion USD | 21.39% |
| 2021 Q4 | 2.43 Billion USD | -18.55% |
| 2021 Q3 | 2.98 Billion USD | 17.51% |
| 2020 Q4 | 2.05 Billion USD | -80.38% |
| 2020 FY | 8.07 Billion USD | -3.77% |
| 2020 Q1 | 1.99 Billion USD | -4.86% |
| 2020 Q2 | 2.29 Billion USD | 15.04% |
| 2020 Q3 | 10.45 Billion USD | 355.73% |
| 2019 Q3 | 2.67 Billion USD | -29.1% |
| 2019 Q4 | 2.09 Billion USD | -21.61% |
| 2019 Q1 | 2.11 Billion USD | -44.46% |
| 2019 Q2 | 3.77 Billion USD | 78.65% |
| 2019 FY | 8.38 Billion USD | 9.16% |
| 2018 FY | 7.68 Billion USD | 2.85% |
| 2018 Q4 | 3.8 Billion USD | 68.8% |
| 2018 Q3 | 2.25 Billion USD | 4.74% |
| 2018 Q2 | 2.15 Billion USD | -20.69% |
| 2018 Q1 | 2.71 Billion USD | -34.46% |
| 2017 Q1 | 2.03 Billion USD | 5.61% |
| 2017 Q2 | 2.58 Billion USD | 27.19% |
| 2017 Q3 | 1.95 Billion USD | -24.58% |
| 2017 Q4 | 4.13 Billion USD | 112.1% |
| 2017 FY | 7.47 Billion USD | 1.91% |
| 2016 FY | 7.33 Billion USD | 3.37% |
| 2016 Q4 | 1.92 Billion USD | -1.63% |
| 2016 Q3 | 1.95 Billion USD | -9.06% |
| 2016 Q2 | 2.15 Billion USD | 12.37% |
| 2016 Q1 | 1.91 Billion USD | -9.62% |
| 2015 FY | 7.09 Billion USD | -15.58% |
| 2015 Q4 | 2.12 Billion USD | 9.0% |
| 2015 Q3 | 1.94 Billion USD | 3.84% |
| 2015 Q1 | 1.86 Billion USD | -16.48% |
| 2015 Q2 | 1.87 Billion USD | 0.7% |
| 2014 Q4 | 2.22 Billion USD | 6.71% |
| 2014 FY | 8.4 Billion USD | 40.39% |
| 2014 Q1 | 2.03 Billion USD | 0.44% |
| 2014 Q2 | 2.05 Billion USD | 1.13% |
| 2014 Q3 | 2.08 Billion USD | 1.56% |
| 2013 FY | 5.98 Billion USD | 26.7% |
| 2013 Q1 | 1.26 Billion USD | -18.55% |
| 2013 Q3 | 1.36 Billion USD | 3.02% |
| 2013 Q4 | 2.02 Billion USD | 48.1% |
| 2013 Q2 | 1.32 Billion USD | 4.49% |
| 2012 Q3 | 1.12 Billion USD | 0.0% |
| 2012 Q4 | 1.55 Billion USD | 38.0% |
| 2012 FY | 4.72 Billion USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -2245.603% |
| Accuray Incorporated | 142.61 Million USD | -5982.725% |
| Align Technology, Inc. | 2.07 Billion USD | -317.705% |
| Elevance Health Inc. | 36.23 Billion USD | 76.06% |
| AxoGen, Inc. | 149.33 Million USD | -5709.048% |
| Boston Scientific Corporation | 7.5 Billion USD | -15.574% |
| CVS Health Corporation | 40.68 Billion USD | 78.679% |
| Cardinal Health, Inc. | 5 Billion USD | -73.5% |
| Centene Corporation | 138.33 Billion USD | 93.729% |
| DaVita Inc. | 1.47 Billion USD | -488.541% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 80.908% |
| Hologic, Inc. | 1.26 Billion USD | -584.364% |
| Humana Inc. | 102.36 Billion USD | 91.525% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -693.802% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | -329.158% |
| Masimo Corporation | 867 Million USD | -900.577% |
| Patterson Companies, Inc. | 1.12 Billion USD | -669.526% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | -438.82% |
| ResMed Inc. | 1.36 Billion USD | -533.965% |
| Henry Schein, Inc. | 2.93 Billion USD | -195.369% |
| Teladoc Health, Inc. | 2.09 Billion USD | -314.886% |
| Universal Health Services, Inc. | 9.2 Billion USD | 5.792% |
| Veeva Systems Inc. | 1.25 Billion USD | -590.109% |
| Baxter International Inc. | 5.27 Billion USD | -64.549% |
| Becton, Dickinson and Company | 6.71 Billion USD | -29.246% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | -192.807% |
| Danaher Corporation | 8.75 Billion USD | 0.914% |
| Stryker Corporation | 9.2 Billion USD | 5.799% |
| Medtronic plc | 16.12 Billion USD | 46.215% |